Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 2 ADMA Adma Biologics (ADMA) Rises Higher Than Market: Key Facts
May 2 AGIO Agios Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 2 AGIO Agios Pharmaceuticals, Inc. (AGIO) Q1 2024 Earnings Call Transcript
May 2 JANX Janux Therapeutics gains amid renewed takeover speculation
May 2 BPMC Blueprint Medicines Corporation (BPMC) Q1 2024 Earnings Call Transcript
May 2 BPMC Blueprint Medicines Corporation 2024 Q1 - Results - Earnings Call Presentation
May 2 DCPH Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
May 2 AGIO Agios Pharmaceuticals Reports Q1 2024 Earnings: Narrower Loss than Expected with Strong Revenue ...
May 2 BPMC Blueprint Medicines Corp Reports Q1 2024 Earnings, Surpasses Revenue Estimates and Raises ...
May 2 AGIO Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates
May 2 BPMC Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates
May 2 AGIO Agios Pharmaceuticals GAAP EPS of -$1.45 beats by $0.20, revenue of $8.19M misses by $0.18M
May 2 BPMC Blueprint Medicines  GAAP EPS of $1.40 beats by $3.05, revenue of $96.12M beats by $14.68M
May 2 ADMA ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
May 2 AGIO Agios Reports Business Highlights and First Quarter 2024 Financial Results
May 2 BPMC Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
May 1 AGIO Agios Pharmaceuticals Q1 2024 Earnings Preview
May 1 BPMC Blueprint Medicines Q1 2024 Earnings Preview
Apr 30 MACK Merrimack Pharmaceuticals announces notification of plan to delist common stock on Nasdaq
Apr 30 MACK Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags